Búsqueda - Portal Conocimiento Público CL

Resultados de búsqueda

Technical documents 2013

Should early antiretroviral therapy (CD4 > 350 cells/mm3) vs deferred antiretroviral therapy (CD4 < 350 cells/mm3) be used for prevention of tuberculosis?

Autor: World Health Organization Suthar, A B Lawn, S D del Amo, J Getahun, H Dye, C Sculier, D Sterling, T R Chaisson, R E Williams, B G Harries, A D Granich, R M

Enlace original: https://apps.who.int/iris/handle/10665/90573

Organización Mundial de la Salud

HIV Infections

Tuberculosis

Anti-Retroviral Agents

Listar archivos Citar Enlace permanente

World Health Organization , Suthar, A B , Lawn, S D , del Amo, J , Getahun, H , Dye, C , Sculier, D , Sterling, T R , Chaisson, R E , Williams, B G , Harries, A D , Granich, R M , [Should early antiretroviral therapy (CD4 > 350 cells/mm3) vs deferred antiretroviral therapy (CD4 < 350 cells/mm3) be used for prevention of tuberculosis?]

Descubre y comparte nuestro conocimiento público

Resultados de búsqueda

Should early antiretroviral therapy (CD4 > 350 cells/mm3) vs deferred antiretroviral therapy (CD4 < 350 cells/mm3) be used for prevention of tuberculosis?

[WHO_HIV_2013.21_eng.pdf]